Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States

Coronavirus 2019 (COVID-19) pneumonia was first noted in Wuhan, China. Since the start of the pandemic, there have been millions of cases diagnosed. The average time from onset of symptoms to testing negative SARS-CoV-2 via reverse transcription polymerase chain reaction is roughly 25 days. In patie...

Full description

Bibliographic Details
Main Authors: Bilal Chaudhry, Lidiya Didenko, Maaria Chaudhry, Andrew Malek, Kirill Alekseyev
Format: Article
Language:English
Published: SAGE Publishing 2021-08-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X211040028
id doaj-5947a1f7417547d187f7b9ce199ae247
record_format Article
spelling doaj-5947a1f7417547d187f7b9ce199ae2472021-08-13T22:03:29ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2021-08-01910.1177/2050313X211040028Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United StatesBilal Chaudhry0Lidiya Didenko1Maaria Chaudhry2Andrew Malek3Kirill Alekseyev4Christiana Care Health System., Newark, DE, USAPost-Acute Medical Rehabilitation Hospital of Dover, Dover, DE, USAChristiana Care Health System., Newark, DE, USAPost-Acute Medical Rehabilitation Hospital of Dover, Dover, DE, USAPost-Acute Medical Rehabilitation Hospital of Dover, Dover, DE, USACoronavirus 2019 (COVID-19) pneumonia was first noted in Wuhan, China. Since the start of the pandemic, there have been millions of cases diagnosed. The average time from onset of symptoms to testing negative SARS-CoV-2 via reverse transcription polymerase chain reaction is roughly 25 days. In patients who continually test positive for COVID-19, it is essential to determine precisely which risk factors contribute to the increase in viral shedding duration. We present a case about a 62-year-old man who has persistently tested positive for COVID-19 for more than 230 days. We followed his treatment course, in which he had been hospitalized multiple times since the onset of symptoms back in April 2020. We have determined that patients with immunosuppression, especially those taking corticosteroids, are at increased risk of prolonged viral shedding. It is essential to continually monitor these immunocompromised patients as they required a greater time period in order to have an appropriate immune response in which antibodies are created.https://doi.org/10.1177/2050313X211040028
collection DOAJ
language English
format Article
sources DOAJ
author Bilal Chaudhry
Lidiya Didenko
Maaria Chaudhry
Andrew Malek
Kirill Alekseyev
spellingShingle Bilal Chaudhry
Lidiya Didenko
Maaria Chaudhry
Andrew Malek
Kirill Alekseyev
Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
SAGE Open Medical Case Reports
author_facet Bilal Chaudhry
Lidiya Didenko
Maaria Chaudhry
Andrew Malek
Kirill Alekseyev
author_sort Bilal Chaudhry
title Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
title_short Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
title_full Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
title_fullStr Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
title_full_unstemmed Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
title_sort longest reported case of symptomatic covid-19 reporting positive for over 230 days in an immunocompromised patient in the united states
publisher SAGE Publishing
series SAGE Open Medical Case Reports
issn 2050-313X
publishDate 2021-08-01
description Coronavirus 2019 (COVID-19) pneumonia was first noted in Wuhan, China. Since the start of the pandemic, there have been millions of cases diagnosed. The average time from onset of symptoms to testing negative SARS-CoV-2 via reverse transcription polymerase chain reaction is roughly 25 days. In patients who continually test positive for COVID-19, it is essential to determine precisely which risk factors contribute to the increase in viral shedding duration. We present a case about a 62-year-old man who has persistently tested positive for COVID-19 for more than 230 days. We followed his treatment course, in which he had been hospitalized multiple times since the onset of symptoms back in April 2020. We have determined that patients with immunosuppression, especially those taking corticosteroids, are at increased risk of prolonged viral shedding. It is essential to continually monitor these immunocompromised patients as they required a greater time period in order to have an appropriate immune response in which antibodies are created.
url https://doi.org/10.1177/2050313X211040028
work_keys_str_mv AT bilalchaudhry longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates
AT lidiyadidenko longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates
AT maariachaudhry longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates
AT andrewmalek longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates
AT kirillalekseyev longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates
_version_ 1721208093781524480